SALUS Ljubljana d. d Past Earnings Performance
Past criteria checks 2/6
SALUS Ljubljana d. d has been growing earnings at an average annual rate of 17.2%, while the Healthcare industry saw earnings growing at 12.2% annually. Revenues have been growing at an average rate of 14.4% per year. SALUS Ljubljana d. d's return on equity is 13.1%, and it has net margins of 1.7%.
Key information
17.2%
Earnings growth rate
16.9%
EPS growth rate
Healthcare Industry Growth | 13.4% |
Revenue growth rate | 14.4% |
Return on equity | 13.1% |
Net Margin | 1.7% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
SALUS Ljubljana d. d (LJSE:SALR) Is Due To Pay A Dividend Of €35.00
Mar 14SALUS, Ljubljana, d. d.'s (LJSE:SALR) 28% Price Boost Is Out Of Tune With Earnings
Feb 06SALUS Ljubljana d. d (LJSE:SALR) Will Pay A Dividend Of €35.00
Dec 30SALUS Ljubljana d. d (LJSE:SALR) Has Announced A Dividend Of €35.00
Apr 05We Think You Should Be Aware Of Some Concerning Factors In SALUS Ljubljana d. d's (LJSE:SALR) Earnings
Mar 22SALUS Ljubljana d. d (LJSE:SALR) Has Announced A Dividend Of €35.00
Mar 12SALUS Ljubljana d. d (LJSE:SALR) Has A Pretty Healthy Balance Sheet
Sep 21We Like These Underlying Return On Capital Trends At SALUS Ljubljana d. d (LJSE:SALR)
Jun 02With EPS Growth And More, SALUS Ljubljana d. d (LJSE:SALR) Is Interesting
May 13These 4 Measures Indicate That SALUS Ljubljana d. d (LJSE:SALR) Is Using Debt Reasonably Well
Apr 22Shareholders Of SALUS Ljubljana d. d (LJSE:SALR) Must Be Happy With Their 274% Total Return
Mar 17Are Strong Financial Prospects The Force That Is Driving The Momentum In SALUS, Ljubljana, d. d.'s LJSE:SALR) Stock?
Feb 12The Price Is Right For SALUS, Ljubljana, d. d. (LJSE:SALR)
Jan 26There's A Lot To Like About SALUS Ljubljana d. d's (LJSE:SALR) Upcoming €25.00 Dividend
Jan 07SALUS Ljubljana d. d (LJSE:SALR) Seems To Use Debt Rather Sparingly
Dec 24How Does SALUS, Ljubljana, d. d. (LJSE:SALR) Fare As A Dividend Stock?
Dec 02Revenue & Expenses BreakdownBeta
How SALUS Ljubljana d. d makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 599 | 10 | 47 | 0 |
30 Sep 23 | 564 | 11 | 44 | 0 |
30 Jun 23 | 537 | 12 | 41 | 0 |
31 Mar 23 | 511 | 12 | 41 | 0 |
31 Dec 22 | 496 | 13 | 40 | 0 |
30 Sep 22 | 496 | 12 | 41 | 0 |
30 Jun 22 | 488 | 12 | 26 | 0 |
31 Mar 22 | 477 | 12 | 39 | 0 |
31 Dec 21 | 458 | 13 | 38 | 0 |
30 Sep 21 | 438 | 14 | 36 | 0 |
30 Jun 21 | 426 | 13 | 35 | 0 |
31 Mar 21 | 407 | 13 | 34 | 0 |
31 Dec 20 | 401 | 10 | 33 | 0 |
30 Sep 20 | 385 | 8 | 32 | 0 |
30 Jun 20 | 368 | 7 | 31 | 0 |
31 Mar 20 | 364 | 6 | 30 | 0 |
31 Dec 19 | 348 | 6 | 29 | 0 |
30 Sep 19 | 320 | 6 | 24 | 0 |
30 Jun 19 | 298 | 5 | 20 | 0 |
31 Mar 19 | 276 | 5 | 16 | 0 |
31 Dec 18 | 253 | 4 | 13 | 0 |
30 Sep 18 | 249 | 3 | 12 | 0 |
30 Jun 18 | 247 | 4 | 12 | 0 |
31 Mar 18 | 239 | 4 | 12 | 0 |
31 Dec 17 | 233 | 4 | 12 | 0 |
30 Sep 17 | 228 | 4 | 11 | 0 |
30 Jun 17 | 226 | 4 | 11 | 0 |
31 Mar 17 | 223 | 3 | 11 | 0 |
31 Dec 16 | 220 | 3 | 11 | 0 |
30 Sep 16 | 213 | 3 | 11 | 0 |
30 Jun 16 | 207 | 3 | 10 | 0 |
31 Mar 16 | 203 | 3 | 10 | 0 |
31 Dec 15 | 200 | 3 | 11 | 0 |
30 Sep 15 | 199 | 4 | 12 | 0 |
30 Jun 15 | 195 | 4 | 13 | 0 |
31 Mar 15 | 191 | 4 | 13 | 0 |
31 Dec 14 | 189 | 4 | 13 | 0 |
30 Sep 14 | 192 | 3 | 12 | 0 |
30 Jun 14 | 194 | 2 | 12 | 0 |
31 Mar 14 | 193 | 2 | 12 | 0 |
31 Dec 13 | 189 | 2 | 12 | 0 |
30 Sep 13 | 182 | 3 | 12 | 0 |
30 Jun 13 | 177 | 3 | 11 | 0 |
Quality Earnings: SALR has high quality earnings.
Growing Profit Margin: SALR's current net profit margins (1.7%) are lower than last year (2.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SALR's earnings have grown by 17.2% per year over the past 5 years.
Accelerating Growth: SALR's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SALR had negative earnings growth (-21.6%) over the past year, making it difficult to compare to the Healthcare industry average (2%).
Return on Equity
High ROE: SALR's Return on Equity (13.1%) is considered low.